“…Its absence in genetically engineered mice and in humans with constitutional genetic defects profoundly influences susceptibility to microbial agents, especially chronic mycobacterial infection. [1][2][3][4] When immunity is triggered inappropriately, as in autoimmune diseases or immune-mediated syndromes such as graft-versus-host disease, [5][6][7] IFN-g appears to mediate inflammation and target cell destruction, negative effects associated with type 1 T cells and Th1 cell response. 8,9 However, the precise roll of IFN-g in animal models, and particularly in human diseases, has not always been easy to define because of conflicting data among experiments and sometimes strikingly poor correlation between murine experiments and the clinic.…”